Brought to you by 
IPO on London exchange nets £18.2mm for Neuropharm Group
06 Mar 2007
Executive Summary
Start-up CNS drug developer Neuropharm Group PLC netted £18.2mm ($35.4mm) in its initial public offering of 15.7mm ordinary shares at £1.27 each on the London Stock Exchange's AIM.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com